Ddavp (desmopressin acetate) NDC 55566-2300

NDC codes

FDA NDC Directory

Product NDC (as listed)55566-2300Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55566-2300Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55566-2300-0	55566230000	1 VIAL, MULTI-DOSE in 1 CARTON (55566-2300-0) / 10 mL in 1 VIAL, MULTI-DOSEMarketed from May 1, 1984

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ddavp
Generic name (nonproprietary): desmopressin acetate
Active ingredients: Desmopressin acetate — 4 ug/mL
Dosage form: Injection
Route: Intravenous
Labeler: Ferring Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018938
Marketing start: May 1, 1984
Listing expires: Dec 31, 2026
Other FDA classes: Increased Coagulation Factor VIII Activity (Physiologic effect)Increased Coagulation Factor VIII Concentration (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 55566-2300_8837d5af-4cd2-4274-a30d-db28acc86364SPL ID 8837d5af-4cd2-4274-a30d-db28acc86364SPL set ID 651f6fee-a2c7-431b-8d5d-58b156c72244RxCUI 849501, 849503, 1723232, 1723234UNII XB13HYU18U
Pharmacologic class: Factor VIII Activator; Vasopressin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455566230000 followed by a unit qualifier and the quantity

Package 55566-2300-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 28, 2022. This label includes a boxed warning.

Indications (excerpt from the label)

DDAVP Injection is a vasopressin analog used for: Central Diabetes Insipidus - as antidiuretic replacement therapy in the management of central (cranial) diabetes insipidus and for the management of the temporary polyuria and polydipsia following head trauma or surgery in the pituitary region. ( 1.1 ) Hemophilia A- for patients with factor VIII coagulant activity levels greater than 5% to maintain hemostasis during surgical procedures and postoperatively or reduce bleeding with episodes of spontaneous or traumatic injuries such as hemarthroses, intramuscular hematomas, or mucosal bleeding. ( 1.2 ) von Willebrand's disease (Type I) - for patients with mild to moderate disease with factor VIII…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 018938

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018938
Product	Strength	Form · route	Labeler	Product NDC
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	SolutionIntravenous	Nordic Pharma, Inc.	69918-899
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	SolutionIntravenous	Nordic Pharma, Inc.	69918-899
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	SolutionIntravenous	Nordic Pharma, Inc.	69918-901
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	SolutionIntravenous	Nordic Pharma, Inc.	69918-901
Desmopressin Acetate	Desmopressin acetate 4 ug/mL	SolutionIntravenous	Nordic Pharma, Inc.	69918-901
Ddavpdesmopressin acetate	Desmopressin acetate 4 ug/mL	InjectionIntravenous	Ferring Pharmaceuticals Inc.	55566-2200